John Owen Brennan

IBRX

John Owen Brennan serves as Director at ImmunityBio, Inc. (IBRX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$70.7K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$70.7K

Companies Traded

IBRX

Active Period

Jun 2023

1 total trades

Most Recent

Buy IBRX

Jun 5, 2023 · $70.7K

John Owen Brennan's Insider Trading at ImmunityBio, Inc. (IBRX)

Buys

1 · $70.7K

Sells

0 · $0.00

Total Shares Bought

25,000

Total Shares Sold

IBRX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 5, 2023	Buy	25,000	$2.83	$70.7K	25,000

Related Insiders

Barry J. Simon

Director

IBRXSell · Oct 6, 2026

Cheryl Cohen

director

IBRXSell · Oct 6, 2026

Christobel Selecky

Director

IBRXSell · Jul 6, 2026

SOON-SHIONG PATRICK

See remarks

IBRXSell · Feb 10, 2026

David C. Sachs

Chief Financial Officer

IBRXSell · Feb 10, 2026

LAUER REGAN J

Chief Accounting Officer

IBRXSell · Feb 10, 2026

Richard Adcock

CEO & President

IBRXSell · Feb 10, 2026

Explore More Insider Trading Data

IBRX Insider Trading Activity

View all insider trades at ImmunityBio, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity